Zusammenfassung
Die pulmonale Langerhans-Zell-Histiozytose kann als reaktive Proliferation von Langerhans-Zellen auf chronischen Tabakrauchkonsum gesehen werden, kann aber auch besonders im Kindesalter als eine tumorartige systemische Erkrankung auftreten. Morphologisch können diese beiden Formen derzeit nicht unterschieden werden. In den Lungen kommt es zu einer nodulären Proliferation von Langerhans-Zellen in der Bronchialmukosa, aber auch peripher in den Alveolarsepten mit einer begleitenden Infiltration durch eosinophile Granulozyten und Zerstörung der Bronchialwand. Die Langerhans-Zellen lassen sich selektiv mithilfe von Antikörpern auf CD1a und Langerin nachweisen. In der reaktiven isoliert pulmonalen Form führt die Abstinenz von Tabakrauch bei den meisten Patienten zu einer Regression der Infiltrate und einer Besserung der Symptome. Radiologisch sind auch nach völliger Tabakrauchabstinenz die kleinen sternförmigen Narben zu erkennen.
Abstract
Pulmonary Langerhans cell histiocytosis is regarded as a reactive proliferation of the dendritic Langerhans cell population stimulated by chronic tobacco-derived plant proteins due to incomplete combustion but can also occur in childhood as a tumor-like systemic disease. Currently, both these forms cannot be morphologically distinguished. In the lungs a nodular proliferation of Langerhans cells occurs in the bronchial mucosa and also peripherally in the alveolar septa with an accompanying infiltration by eosinophilic granulocytes and destruction of the bronchial wall. Langerhans cells can be selectively detected with antibodies against CD1a and langerin. In the reactive isolated pulmonary form, abstinence from tobacco smoking in most patients leads to regression of infiltration and improvement of symptoms. In high-resolution computed tomography (HRCT) the small star-like scars can still be detected even after complete cessation of tobacco smoking.
Literatur
Ackerman AJ (1947) Eosinophilic granuloma of bones associated with involvement of the lungs and diaphragm. Am J Roentgenol Radium Ther 58(6):733–740
Parkinson T (1949) Eosinophilic xanthomatous granuloma with honeycomb lungs. Br Med J 1(4614):1029
Dickson DD (1948) Eosinophilic granuloma of bone with diffuse pulmonary involvement. Calif Med 69(1):51–53
Nadeau PJ, Ellis FH Jr, Harrison EG Jr, Fontana RS (1960) Primary pulmonary histiocytosis X. Dis Chest 37:325–339
Weiss W, Johnston DG (1957) Pulmonary histiocytosis X. Am Rev Tuberc 75(2):319–325
Friedman PJ, Liebow AA, Sokoloff J (1981) Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 60(6):385–396
Knudson RJ, Badger TL, Gaensler EA (1966) Eosinophilic granuloma of the lung. Med Thorac 23(4):248–262
Lichtenstein L (1964) Histiocytosis X (Eosinophilic Granuloma of Bone, Letterer-Siwe Disease, and Schueller-Christian Disease). Further observations of pathological and clinical importance. J Bone Joint Surg Am 46:76–90
Cline MJ (1994) Histiocytes and histiocytosis. Blood 84(9):2840–2853
Nezelof C, Basset F (1998) Langerhans cell histiocytosis research. Past, present, and future. Hematol Oncol Clin North Am 12(2):385–406
Chikwava KR, Hunt JL, Mantha GS, Murphy JE, Jaffe R (2007) Analysis of loss of heterozygosity in single-system and multisystem Langerhans’ cell histiocytosis. Pediatr Dev Pathol 10(1):18–24
Badalian-Very G, Vergilio JA, Degar BA et al (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116(11):1919–1923
van Nieuwenhuijze AE, Coghill E, Gray D et al (2014) Transgenic expression of GM-CSF in T cells causes disseminated histiocytosis. Am J Pathol 184(1):184–199
Chilosi M, Facchetti F, Calio A et al (2014) Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis. Leuk Lymphoma 55(11):2620–2626
Sundar KM, Gosselin MV, Chung HL, Cahill BC (2003) Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest 123(5):1673–1683
Attili AK, Kazerooni EA, Gross BH et al (2008) Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics 28(5):1383–1396 (discussion 96–98)
Popper HH (2000) Bronchiolitis, an update. Virchows Arch 437(5):471–481
Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E (1999) Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 94(12):4195–4201
Uebelhoer M, Bewig B, Sternberg K et al (1995) Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes. Lung 173(3):187–195
Costabel U, Guzman J, Bonella F, Oshimo S (2007) Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 28(5):514–524
Dziegiel P, Dolilnska-Krajewska B, Dumanska M et al (2007) Coexpression of CD1a, langerin and Birbeck’s granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies. Folia Histochem Cytobiol 45(1):21–25
Wilejto M, Abla O (2012) Langerhans cell histiocytosis and Erdheim-Chester disease. Curr Opin Rheumatol 24(1):90–96
Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ (2012) Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol 156(2):163–172
Routy B, Hoang J, Gruber J (2015) Pulmonary langerhans cell histiocytosis with lytic bone involvement in an adult smoker: regression following smoking cessation. Case Rep Hematol 2015:201536
Yousem SA, Dacic S, Nikiforov YE, Nikiforova M (2013) Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 143(6):1679–1984
Roden AC, Hu X, Kip S et al (2014) BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 38(4):548–551
Shahla A, Parvaneh V, Hossein HD (2004) Langerhans cells histiocytosis in one family. Pediatr Hematol Oncol 21(4):313–320
Arceci RJ (2014) Biological and therapeutic implications of the BRAF pathway in histiocytic disorders. Am Soc Clin Oncol Educ Book 2014:e441–e445
Wei R, Wang Z, Li X, Shu Y, Fu B (2013) Frequent mutation has no effect on tumor invasiveness in patients with Langerhans cell histiocytosis. Biomed Rep 1(3):365–368
Hutter C, Kauer M, Simonitsch-Klupp I et al (2012) Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood 120(26):5199–5208
Murakami I, Morimoto A, Oka T et al (2013) IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy. Virchows Arch 462(2):219–228
Coury F, Annels N, Rivollier A et al (2008) Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 14(1):81–87
Nelson DS, van Halteren A, Quispel WT et al (2015) MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer 54(6):361–368
Kawauchi Y, Kuroda Y, Kojima N (2012) Preferences for uptake of carbohydrate-coated liposomes by C-type lectin receptors as antigen-uptake receptors. Glycoconj J 29(7):481–490
Chabrol E, Nurisso A, Daina A et al (2012) Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode. PLoS One 7(11):e50722
Salazar F, Ghaemmaghami AM (2013) Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells. Front Immunol 4:356
Lambrecht BN, Hammad H (2014) Allergens and the airway epithelium response: gateway to allergic sensitization. J Allergy Clin Immunol 134(3):499–507
Santiago-Schwarz F (1999) Positive and negative regulation of the myeloid dendritic cell lineage. J Leukoc Biol 66(2):209–216
Bartlett JA, Fischer AJ, McCray PB Jr (2008) Innate immune functions of the airway epithelium. Contrib Microbiol 15:147–163
Karo JM, Sun JC (2015) Novel molecular mechanism for generating NK-cell fitness and memory. Eur J Immunol 45(7):1906–1915
Satpathy AT, Chang HY (2015) Long noncoding RNA in hematopoiesis and immunity. Immunity 42(5):792–804
Haniffa M, Bigley V, Collin M (2015) Human mononuclear phagocyte system reunited. Semin Cell Dev Biol 41:59–69
Fischer A (2015) Recent advances in understanding the pathophysiology of primary T cell immunodeficiencies. Trends Mol Med 21(7):408–416
Egeler RM, van Halteren AG, Hogendoorn PC, Laman JD, Leenen PJ (2010) Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage. Immunol Rev 234(1):213–232
Koethe SM, Kuhnmuench JR, Becker CG (2000) Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol 157(5):1735–1743
Youkeles LH, Grizzanti JN, Liao Z, Chang CJ, Rosenstreich DL (1995) Decreased tobacco-glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 151(1):145–150
Popper HH (1999) Epithelioid cell granulomatosis of the lung: new insights and concepts. Sarcoidosis Vasc Diffuse Lung Dis 16(1):32–46
Fisher GM, Iqball S, Knight SC (1999) Gene expression during differentiation of human dendritic cells from cord blood cd34 stem cells. Cytokine 11(2):111–117
Popper HH (2013) Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update. Virchows Arch 462(1):1–26
Hyman DM, Diamond EL, Vibat CR et al (2015) Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders. Cancer Discov 5(1):64–71
Emile JF, Diamond EL, Helias-Rodzewicz Z et al (2014) Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. Blood 124(19):3016–3019
Park HJ, Jeon YK, Lee AH et al (2012) Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells. Am J Surg Pathol 36(8):1150–1117
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H.H. Popper gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Additional information
Schwerpunktherausgeber
F. Fend, Tübingen
Rights and permissions
About this article
Cite this article
Popper, H. Die pulmonale Langerhans-Zell-Histiozytose. Pathologe 36, 451–457 (2015). https://doi.org/10.1007/s00292-015-0052-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-015-0052-9